Oarsman Capital’s State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF CERY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577K Sell
17,265
-7,198
-29% -$259K 0.06% 130
2026
Q1
$862K Sell
24,463
-25
-0.1% -$804 0.11% 95
2025
Q4
$699K Buy
24,488
+6,728
+38% +$197K 0.09% 121
2025
Q3
$509K Buy
17,760
+955
+6% +$26.6K 0.07% 141
2025
Q2
$458K Buy
16,805
+5,020
+43% +$135K 0.07% 154
2025
Q1
$327K Sell
11,785
-250
-2% -$6.76K 0.06% 169
2024
Q4
$312K Buy
+12,035
New +$313K 0.05% 174

Other funds holding CERY

Oarsman Capital's CERY Position: Q2 2026 in Review

Oarsman Capital reduced its State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF (CERY) stake by 29% in Q2 2026, selling an estimated $259K and leaving 17,265 shares worth $577K. The position accounts for 0.06% of the portfolio, ranked #130.

Oarsman Capital first reported a position in CERY in Q4 2024 and has held it in 7 quarters since. The position peaked at $862K in Q1 2026. 129 funds tracked by Wall St. Rank hold CERY as of Q2 2026.

  • Oarsman Capital held 17,265 shares of State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF worth $577K as of Q2 2026.
  • Oarsman Capital sold 7,198 State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF shares in Q2 2026, an estimated $259K.
  • State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF made up 0.06% of Oarsman Capital's portfolio in Q2 2026, its #130 holding.
  • Oarsman Capital first reported a position in State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF in Q4 2024 and has held it in 7 quarters since.
  • Oarsman Capital's State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF position peaked at $862K in Q1 2026.
  • 129 funds tracked by Wall St. Rank held State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF as of Q2 2026.

Based on Oarsman Capital's 13F filing for Q2 2026, filed 7 Aug 2026.